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Abstract
Shared decision making (SDM) is acknowledged as 
the gold standard of healthcare communication, 
particularly relevant to preference-sensitive care such 
as breast cancer treatment. However, research on 
patients’ experiences shows a misalignment between 
clinicians’ goals and the rhetoric regarding patients’ 
empowerment during SDM for this treatment. This 
warrants detailed examination on the conversational 
dynamics of SDM, and this study aims to identify 
interactional features and social practices through 
which SDM is achieved.
 Fifteen audio recordings from adjuvant treatment 
breast cancer consultations were examined using the 
methodology of conversation analysis (CA), and recur-
rent patterns relevant for understanding SDM were 
identified. Boundary markers, rhetorical questioning 
and epistemic markers discouraged a shared orien-
tation to patient participation, reinforcing perceived 
imbalanced doctor–patient power relations. Cues 
for SDM such as multi-turn utterances and spaces 
for transition were presented but not recognised by 
patients, resulting in sub-optimal two-way discussions 
about decision making.
 The findings also reveal that interactional practices 
were deployed that theoretically should have enabled 
patients to contribute to SDM. However, in reality 
these did not result in extended sequences of recip-
rocated contributions from practitioner and service 
user. SDM did not happen with the ease implied by 
current models, and the resultant interactions bore 
more similarity to expert-led, rather than collabora-
tive, decision making.
Keywords: breast cancer; conversation analysis; 
doctor–patient communication; doctor–patient rela-
tionship; shared decision making
1. Introduction
Effective doctor–patient communication is 
deemed pivotal to determining good interpersonal 
relationships and facilitating exchange of informa-
tion, patients’ commitment to treatment regimens 
and patient satisfaction (Ha and Longnecker 2010). 
However, despite its importance, evidence presents 
multiple barriers to good communication in the 
doctor–patient relationship, including patients’ 
anxieties and fears, practitioner workload, fear 
of litigation and unrealistic patient expectations 
(Fentiman 2007)
In the UK, guidelines produced by the 
Department of Health (2010) and its National 
Institute for Health and Care Excellence (2016) 
advocate a patient-centred healthcare system 
built around shared decision making (SDM). SDM 
comprises both the patient and clinician making 
decisions after openly exchanging information, 
exploring beliefs and reaching explicit closure 
(Elywn et al. 2012). However, it means more 
than just patient autonomy and preferences: it 
represents an important shift in the roles of both 
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patients and clinicians, moving away from a pater-
nalistic doctor–patient relationship (Barry and 
Edgman-Levitan 2012). Evidence indicates that 
implementation of SDM in secondary healthcare 
has been successful insofar as embedding decision 
support tools (Frosch et al. 2011; Elwyn et al. 2012) 
and training clinicians (Légaré et al. 2010), but that 
difficulties remain, with SDM in practice appearing 
slow, complex and situational (Berger 2015). This 
is particularly so in the context of breast cancer 
care, as factors such as the patient’s participatory 
role and a perceived discrepancy in doctor–patient 
knowledge and role expectations appear to hinder 
SDM (Joseph-Williams et al. 2014; Mahmoodi and 
Sargeant 2017).
An exploration of interactional practices associ-
ated with doctor–patient relationships and forms 
of patient participation during consultations in this 
specific context would enable a deeper understand-
ing of the barriers to and complexities of SDM. 
Drawing on the framework of conversation analysis 
(CA) and as part of a case study methodology, this 
paper examines how SDM transpires during adju-
vant consultations about post-surgical treatment 
for breast cancer. The methodological framework 
of CA is used to explore conversations between 
15 women with breast cancer and an oncologist 
clinician. The paper outlines in the findings certain 
interactional practices which discourage patient 
participation and meaningful SDM, and concludes 
by offering implications for clinical practice to 
support SDM in breast cancer care.
2. Literature review
SDM can be a disruptive idea because it demands 
shifts in the power and control of interactions 
between clinicians and patients, and as reasons 
clinicians cite time limitations, lack of perceived 
relevance to the patient or clinical situation and 
patients’ preferences for decision making as 
barriers to the effective implementation of SDM 
(Légaré et al. 2008; Joseph-Williams et al. 2014; 
Berger 2015). Further, preferences for participat-
ing in SDM vary amongst patients (Mahmoodi 
and Sargeant 2017), with some patients initially 
resisting the ‘active’ patient role and declining 
decisional responsibility (Elwyn et al. 2012) due 
to long-standing cultural beliefs about the user 
as a ‘passive spectator’. Factors contributing to 
this phenomenon include the perceived burden 
of making choices (De Haes 2006), and perceived 
discrepancy in doctor–patient expertise and roles 
(Joseph-Williams et al. 2014).
Some researchers argue that the inherently 
unequal power dynamic and asymmetry in doctor–
patient roles prevent the successful implementa-
tion of SDM (Pilnick and Dingwall 2011; Frosch et 
al. 2012; Joseph-Williams et al. 2014; Mahmoodi 
and Sargeant 2017). From a practitioner perspec-
tive, clinicians may feel threatened by the concept 
of patient empowerment and be unwilling to adopt 
practices that challenge existing power dynam-
ics, even if broadly supportive of SDM (O’Flynn 
and Britten 2006). Although some interventions 
address such power imbalances and challenge 
‘non-compliant’ attitudes (Shepherd et al. 2011; 
Joseph-Williams et al. 2017), agreement on how 
best to integrate these into routine healthcare 
settings is elusive.
The interactional dimensions of SDM has 
received much scholarly attention, with the aim of 
better understanding doctor–patient relationships. 
Studies document the particular foci of clinical 
communication and the communicative behav-
iours of health professionals that may facilitate 
SDM (Duffin and Sarangi 2018; Lee et al. 2018), 
and evidence suggests that providing patients with 
certain skills (e.g., asking questions, verifying infor-
mation) can lead to their more active involvement 
in decision making (Alegría et al. 2014). Attention 
has long been paid to the notion of asymmetry in 
conversations (Linell and Luckmann 1991) and 
this extends to more detailed explorations of how 
this transpires in clinical encounters, specifically 
unilateral and bilateral classifications assigned to 
conversations about cancer treatment (Collins et 
al. 2005)
CA research on doctor–patient encounters has 
focused almost exclusively on traditional consul-
tations (Heritage and Stivers 1999; Peräkylä 1999; 
Heritage and Maynard 2005). Although a small 
body of research has deployed CA to examine SDM 
in healthcare settings (Elywn et al. 1999; Landmark 
et al. 2015), many clinical specialities remain unex-
amined. One area of clinical practice where SDM 
has been identified as the prevailing approach for 
doctor–patient treatment decision making is in 
breast cancer care (Charles et al. 2004; Chewning 
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et al. 2012), a form of care that necessitates complex 
preference-sensitive decision making (i.e. when 
more than one treatment option is available and 
there is no single ‘best’ choice for every case) 
and that may present specific issues in relation to 
SDM. Earlier work indicates the positive impact of 
SDM on patient outcomes (Street and Voigt 1997); 
however, more recent studies highlight the particu-
lar issue of unequal power dynamics in relation to 
using this model effectively with this population 
(Keating et al. 2002; Mahmoodi and Sargeant 
2017). Given this, a detailed examination of the 
interactions between breast cancer patients and 
health professionals may identify both hindrances 
and enablers of SDM in this clinical context.
3. Data and methods
3.1. Sample and participants
Data were collected from a National Health 
Service (NHS) outpatient breast cancer oncology 
clinic from a UK hospital cancer centre. The study 
was approved by the local NHS Research Ethics 
Committee (Ref: 12/NW/0140), and the Hospital 
Research and Development Department (Ref: 
DC/hr)
All patient participants in this study were 
female. While it is acknowledged that men can 
also be diagnosed with breast cancer, the paper 
refers to a solely female sample. The data comprised 
audio recordings of initial breast cancer oncology 
consultations. These recordings were routinely 
made by clinicians and not initially produced for 
research purposes but instead to serve as a record 
for the women patients themselves to refer to 
should they need to. These recordings were made 
upon their verbal consent at the start of the con-
sultation and existed prior to the conception and 
commencement of this study. It is worth noting 
that with the advent of telehealth and digitisation 
of many health records, there is increased evidence 
of opportunistic data utilisation from healthcare 
consultations (Chatwin et al. 2014).
Written informed consent was obtained from 
25 women to access their recordings for analysis. 
All were aged 18+ and were contacted as regis-
tered patients of the breast cancer unit. They had 
undergone breast surgery and were referred to the 
oncology clinic for adjuvant treatment. Inclusion 
criteria required an initial oncology consultation 
two months prior to the time of recruitment. This 
timeframe was suggested by breast cancer health 
professionals to be an appropriate period for the 
patients to have adjusted to treatment and made 
use of the recording.
Fifteen women agreed to supply their record-
ing, five declined and the remaining five did 
not respond. This provided 15 doctor–patient 
encounters (audio recordings) for analysis. The 
mean age of the consenting women was 51 years 
(range 40–63), and all of them had undergone 
chemotherapy, radiotherapy or hormone therapy 
as adjuvant treatment. All interactions took place 
between the female participants and the same one 
male senior oncologist clinician. In the context of 
CA and doctor–patient interaction, a case-based 
methodology is not uncommon (Elwyn et al. 1999; 
Chatwin 2014). A single case study approach on 
one clinician enables a detailed holistic investi-
gation and captures the emergent and immanent 
properties and complex interactional details of 
SDM within its real-life context. This approach 
allows readers to make judgements about applica-
bility rather than making a case for generalisability.
3.2. Analytical procedure
The practice of CA aims to explicate the shared 
practices that constitute social interaction from 
speakers’ behaviours. This approach enables the 
identification of shared practices through which 
people accomplish particular actions. For example, 
CA research on medical encounters has iden-
tified certain practices for initiating advice and 
questioning to elicit patients’ concerns (Robinson 
2001; Stivers and Heritage 2001; Peräkylä 2002). 
A detailed CA was conducted on all 15 audio 
recordings (total of 801 minutes), which were 
transcribed in their entirety by NM according 
to Jefferson’s (2004) transcription system (see 
Appendix). Anonymity was preserved in the 
extracts by using pseudonyms. CA was performed 
by locating patterns, structures and practices of 
talk-in-interaction, noting structural, turn-taking, 
turn-design and sequence organisation (Drew et 
al. 2001; Heritage and Maynard 2005). Validity of 
transcription and analysis was sought by applying 
aspects suggest by Arminen (2005) – transparency, 
validation by next turn, participant’s validation 
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– and by holding data sessions with another experi-
enced CA researcher (TM). Reflexive commentary 
was carried out by NM, using a reflexive diary, as 
a means to measure any subjectivity or influences 
during interpretations (Willig 2008).
4. Findings
During preliminary analysis, three themes emerged 
as influencing SDM. These themes display CA 
features which either deter or elicit doctor–patient 
collaborative interaction. Extracts from various 
consultations (consultation ID provided) are pre-
sented below to illustrate these themes between 
the patients (P) and the oncologist clinician (C).
4.1. Theme 1: Epistemic status in SDM
Extract 1 illustrates how the clinician indexes the 
epistemic status associated with medical knowl-
edge and to the deontic right – that is, the right 
to determine actions – as a way to promote a pro-
posed treatment plan. The practice of sequential 
positioning reinforces medical authority and the 
clinician’s view as primary, which may not open a 
space for subsequent patient involvement.
Extract 1. (consultation ID 4)
1 C: <So yes> we would want to give you 
2  some treatment 
3  (0.9)
4 C: >We would< suggest that we give 
5  you chemo:therapy (.) >given< 
6  your illness history 
7  (1.0)
8 C: This is something we pre:fer (.)
9  as this is the only thing we kno:w 
10  that is very likely to improve the 
11  chances that we have got rid of it 
12  completely
The clinician and the patient enter a conversation 
about chemotherapy, as a possible adjuvant treat-
ment plan. The clinician starts by showing a col-
laboration between medical colleagues (‘we would 
want’) about the need for further treatment. The 
term ‘we’ signifies a majority group that excludes 
the patient, thus self-situating the clinician’s 
deontic order (clinician’s responsibility) and epis-
temic status. Such claims for epistemic rights and 
the defining of the grounds for decision making 
are reflected in lines 8–12, through the clinician’s 
portrayal of knowledge (‘the only thing we know’ 
and ‘it is very likely to improve’) and by drawing 
on medical authority (‘with your illness history’). 
The steep deontic gradient arguably reduces the 
likelihood of counterarguments, which is most 
obvious in the statement ‘something we prefer’ (line 
8), following a delayed acknowledgement token 
from the patient.
Despite decision making being framed in terms 
of the clinician’s expertise and actions, the patients 
were also given various opportunities to express 
their views following those presented by the clini-
cian, as illustrated in the next extract. Extract 2 also 
shows the impact of sequential positioning, but 
with the clinician setting up varying deontic and 
epistemic gradients as shifts are made from ‘we’, ‘I’ 
and ‘you’, to illustrate varying degrees of decisional 
responsibility between the doctor and the patient.
Extract 2. (consultation ID 7)
1 C: I would <very stron:gly> advise you 
2  to have chemo 
3  (0.5)
4 C: It then makes cure the most likely 
5  thing↑
6  (4.0)
7 C: I would be concerned↑ if you didn’t 
8  take the treatment (0.1) as you would 
9  not be giving yourself the most likely 
10  chance>
11  (3.8)
12 C: Would there be a reason why you 
13  would consider not taking it?↑
14  (2.5)
15 P: No (0.2) reading about the 
16  chemotherapy, I know it’s rare 
17  to get cancer elsewhere as a 
18  side-effect.
19 P: But I don’t kno:w anything
20  about it?
20  (1.2)
21 C: Yes↑ (.) and I just feel(.)in my view 
22  >so to not< take it for that risk (0.9) 
23  >so to increase< your risk of it 
24  coming back and not being cured<
24  (2.9)
This extract is taken from a conversation about why 
chemotherapy would be a better treatment option. 
In lines 1–5, the clinician initially presents a ‘we/I’ 
perspective by framing the talk about chemother-
apy as led, and to some extent determined by, the 
44  Neda Mahmoodi, Georgina L. Jones, Tom Muskett and Sally Sargeant
health professionals. Such sequential positioning 
of ‘we/I’ is a clear delineated presentation of the 
medical viewpoint and decision making about 
treatment, to which the patient viewpoint comes 
second, and is sequentially invited as secondary to 
the clinician’s opinion.
This is further reflected in the patient’s lack 
of turn taking until asked a direct question (line 
12). Even then, the patient’s response options 
are constrained: the direct question is designed 
in such a way that it projects for a ‘no’ response 
(Pomerantz 1984), accordingly delivered in line 15. 
However, by providing spaces and opportunities 
within this structure, the clinician tries to obtain 
some approval from the patient and invites her 
specifically to share her views and thoughts on 
the treatment proposal. For instance, the clinician 
changes use of the pronoun ‘we/I’ to ‘you’, which 
marks a shift in whose decision it is (line 12). While 
the medical ‘we/I’ (i.e. the clinician) would choose 
chemotherapy, ‘you’ (i.e. the patient) would have 
the possibility to choose differently.
This conveys a subtle shift and sharing of respon-
sibility, which lies with the patient in choosing the 
suggested treatment option. Although showing 
agreement with the clinician, the patient backs 
her response with a disclaimer of knowledge: ‘But 
I don’t know anything about it’ (lines 19–20). This 
disclaimer aids withdrawing any of the patient’s 
deontic stances and draws on their asymmetrical 
epistemic status: in claiming a lack of knowledge, 
the patient indirectly defers to the clinician to be 
knowledgeable and the real decision-maker. This 
is also explicated in the increment by the clinician 
in lines 21–24, portraying chemotherapy as the 
routine option to enhance cure, which indirectly 
draws on the deontic authority of the medical 
community. The clinician displays a positive 
acknowledging response (lines 20–24) and utilises 
the patient’s response to further stress the impor-
tance of chemotherapy, along with stance-taking 
language such as ‘I just feel’ and ‘in my view’ as 
well as reference to potential negative outcomes 
of cancer, e.g. ‘coming back’ and ‘not being cured’.
4.2. Theme 2: Orientation to deter SDM
The use of boundary markers and asymmetrical 
questioning became apparent during the consul-
tations. On the one hand, rhetorical questioning 
posed by the clinician functioned to structure the 
content of the consultation and to provide the 
patient with appropriate health information to 
make an informed decision, but it also generated 
one-way interaction. The boundary marker ‘so’ 
directed or redirected the flow of conversation 
without adding any significant paraphrased 
meaning to the discourse (Fraser 1999). Both 
phenomena, evident in Extracts 3 and 4 below, 
operated as a turn-holding device for the clinician, 
thus negating collaborative discussions around 
decision-making.
Extract 3. (consultation ID 11)
1 C: There is a sma:ll cha:nce there 
2  are micro:scopic cells left* (.) and if 
3  we did nothing they will gro:w and 
4  the cancer will come back- 
5  (2.5)
6 C: If↑ that is the ca:se (.) what can we 
7  do n:ow to get rid of them? 
8  (1.0)
9 C: S:o (0.2) we think about thre:e areas
10  (1.0) to build a picture of risk-
At the start of consultation in Extract 3, the clini-
cian begins by talking about the patient’s current 
health status. Following some delicate and qualified 
talk about the risk of microscopic cancer cells still 
being present (line 6–7), a question is posed by 
the clinician about how these hypothetically could 
be removed. Epistemically, this is a question that 
the clinician rather than the patient is positioned 
to answer, and accordingly the patient treats it as 
rhetorical by not responding. The clinician takes 
his turn (line 9) by providing an answer, thereby not 
pursuing the unanswered question. This answer 
is constructed as a cumulative process to ‘build 
a picture of risk’, opening with the clear bound-
ary marker ‘so’. The use of this boundary marker 
signifies the start of a new phase of talk (i.e. the 
answer) and, therefore, instructs the patient to 
listen. The marker most importantly functions as 
a connection to what has come previously (i.e. the 
question) whilst opening further space for the cli-
nician to maintain the conversation for an extended 
descriptive answer of the ‘three areas’.
This technique of questioning followed with ‘so’ 
was manifest on several occasions with various 
patients. Extract 4 illustrates the complexity of this 
action in more detail with another patient.
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Extract 4. (consultation ID 1)
1 C: Is there a benefit to 
2  chemotherapy? 
3  (2.0)
4 C: So- >percentage wise< there is 
5  n:o benefit. 
6  (0.1) 
7 C: it m:ay have some 
8  detriment (.) >which is the 
9  side-effects< 
10  (3.0) 
11 C: S:o (1.5) <ho:w certain> 
12  are we of this result? 
13  (2.1)
14 C: Well (.) it cou:ld be that there is↑ 
15  a small benefit of chemotherapy
16  (0.2) 
17 C: We thi:nk there is 
18  absolutely non-↓ 
19  (2.0) 
20 C: Is this ok for yo:u?
21  (1.5)
22 P: If you think so?
23  (1.0)
24 C: I do↑
With this patient, the risks vs benefits of treatment 
are being discussed. A question which requires 
expert knowledge is stated by the clinician in line 1. 
Similar to Extract 3, the same effect is achieved as 
evidenced by no patient interaction, and therefore 
the next turn construction unit (TCU) is once again 
taken by the clinician (line 4). The clinician opens 
with ‘so’ as a boundary marker, which is used to 
introduce the answer to the previous unanswered 
question: it is suggested that there is statistically ‘no 
benefit’ to chemotherapy. The clinician strengthens 
this case further in lines 7–8, by stating that there 
is a ‘detriment’, a major loss or damage to the self, 
as a result of the side-effects of chemotherapy. The 
patient does not respond, which indicates that 
up to this point the clinician has presented good 
clinical reasoning for not having chemotherapy.
The clinician starts the next TCU in line 11 
with once again the boundary marker ‘so’, which 
here indicates a conclusive result (at the discursive 
level of facts). Additionally, the clinician assesses 
the decision by once again asking a question about 
the certainty of the test results (lines 11–12). The 
same action by the patient is displayed, as there 
is no response, and instead the clinician provides 
an answer. The reasoning over treatment is then 
finally closed in lines 17–18, as the clinician 
concludes that, in fact, the benefit is ‘absolutely 
none’.
The formulation of the direct question ‘is it 
okay for you?’, with a prolonged ‘you’, represents 
a request for patient permission. Thus, the clini-
cian acknowledges the patient’s choice to accept 
or reject this treatment suggestion. However, the 
interactional style used to present only one of the 
options displays a preference for a confirming 
response, thus adding pressure on the patient to 
affiliate with the clinician’s expertise and role. This 
disaffiliative stance is further expressed by the 
patient’s subsequent account of ‘if you think so?’, 
which invites the clinician’s medical opinion for 
practical efficiency to be the proper grounds for 
the decision.
4.3. Theme 3: Utterances to initiate SDM
Despite there being evidence of the clinician 
offering opportunities for SDM through sharing 
deontic responsibility (Extract 2) and making 
explicit reference to patient choice (Extracts 2 and 
4), in these cases the patient is not sequentially 
positioned to participate interactionally. Extracts 5 
and 6 demonstrate how further attempts are made 
to encourage patient participation, but the role of 
multi-turn utterances inhibits clear projections of 
a relevant second pair part (SPP), thereby leaving 
long periods of silence in the talk. It is only through 
direct first pair part (FFP) questioning that turn 
taking is acknowledged by the patient.
Extract 5. (Consultation ID: 14)
1 C: >Firstly< we took a margin of normal 
2  breast tissue for testing(.)
3  to see if it is hormone receptor
4  sensitive or positive
5  (1.8)
6 C: After that(.) we tested it to see if it is 
7  over producing the protein called 
8  her2
9  (1.2)
10 C: Indeed it was stron:gely hormone 
11  receptive positive (.) >and that
12  good<↑
13  (3.6) 
14 C: That tells us hormone therapy (.)can 
15  be used for part of the tre:atment. 
16  (3.8) 
17 C: An:y questions so far on that- before 
18  we move on to hormone treatment?




22 C: S:o (.)
23  (1.2) 
24 C: Hor:mone treatment in↑volves tablets.
In this extract, the clinician is medically explaining 
why hormone treatment would be appropriate for 
the patient. It is noticeable that long periods of 
silence (particularly in lines 16 and 21) occur at 
the end of each completed TCU by the clinician. 
During these periods of silence, the clinician and 
the patient appear to do nothing, and no one talks. 
The silence could be as a result of the conversa-
tion format. For instance, each of the clinician’s 
statements is not a clear FFP that signals an SPP 
response. This suggests that both speakers could 
legitimately speak, and the silence is not attribut-
able to any particular speaker.
Also, the interactional features indicate to the 
patient that the clinician’s explanation is not fin-
ished yet. For example, the clinician illustrates a 
turn-holding device by methodically introducing a 
diagnostic narrative through the use of sequential 
timing words (e.g. ‘firstly’ in line 1 and ‘after that’ 
in line 6). Another turn-holding device is the use 
of extended multi-turn utterances which do not 
mark a clear SPP and which make it relevant for the 
clinician to take the next turn in order to present 
his thoughts, and make transitions in talk from him 
to the patient harder.
Once the clinician’s explanation and reasoning 
are fully presented, the patient is asked a direct 
question (lines 17–18), with a long gap of 4.7 
seconds once having completed a TCU. Unlike the 
gaps earlier in the conversation, this long silence 
has occurred after the spoken FPP question to the 
patient. This therefore creates a TRP, in which the 
patient can interpret that an SPP is expected by 
them (achieved in line 20). Following the patient’s 
minimal response, a prolonged pause in talk is 
once again presented (line 21). The clinician takes 
the turn with a stretched boundary marker of ‘so’ 
(line 22) to display thinking through, and this also 
functions as a marker of connection to the patient’s 
response. A TCU of 1.2 seconds is provided in line 
23, which now deploys a stand-alone ‘so’. This is 
used to further prompt the patient to produce the 
next relevant response, and perhaps to elaborate 
on her minimal response of ‘no’. However, with 
the turn not taken up by the patient, the term ‘so’ 
therefore becomes used to preface a topic beginner.
Other interactional devices, besides direct FPP 
questioning, were also used by the clinician to 
attempt to scaffold the patient into SDM, as illus-
trated in Extract 6.
Extract 6. (consultation ID: 9)
1 C: <Do you want to> under those 
2  circumstances? 
3  (3.0)
4 C: For a small benefit
5  (3.5)
6 C: You might say right- I want 
7  chemotherapy because I want that 
8  small benefit (.)>or you might say< 
9  (.) no I DO NOT even want to bother 
10  as it’s <such a small gain>
11  (3.8)
12 C: But we will be dealing with 
13  philosophy of how you would want 
14  to be treat:ed (.) rather than the 
15  science
16  (2.0)
17 C:  But with this onco-type test we can 
18  actua:lly now drill down 
19  >a little bit< further↑ (0.1) we now 
20  move to the science which says that 
21  NO ONE WANTS TO do it because 
22  there is abs:olutel:y <no point>
In this extract, a conversation is taking place about 
the lack of benefits of chemotherapy as a treatment 
option. A direct question (lines 1–2) is asked to 
elicit the patient’s views about chemotherapy. The 
term ‘under those circumstances’ renders as a qual-
ified question and could cause some difficulty in 
the patient answering, as it is tied to the technical 
knowledge previously given to the patient about 
side-effects of this treatment.
Unlike in the previous extracts, the clinician 
does not interpret the absence of response as a 
turn-holding device, but rather that there may be a 
problem with the prior direct question. To address 
this, an increment is added in line 4, to scaffold the 
patient towards medical evidence. This increment 
subsequently causes the silence to be an intra-turn 
silence, which in a sense undoes the fact that the 
patient is not speaking. By stating ‘for a small 
benefit’, the nature of the initial question is changed, 
as the clinician is now apparently projecting for 
a particular response. More supportive attempts 
are presented by the clinician, in lines 6–10, to 
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facilitate SDM by modelling possible responses. To 
reduce the complexity of the process, the clinician 
hypothetically speaks on behalf of the patient. 
The patient is made aware that there is no right 
or wrong answer to the question, as the clinician 
presents two opposing types of answers. Despite 
these turns potentially supporting patient partic-
ipation, the patient’s response, however, remains 
absent (line 11).
Consequently, in lines 12–15 the conversation 
turns from the philosophical concept of ‘reality’ 
to science and evidence-based decision making, 
whereby clinical results and numerical statistics 
are once again topicalised to provide the patient 
with what is regarded by the clinician as a preferred 
answer to the original question asked in line 1. 
The patient is presented with two extreme case 
formulations in lines 21–22, which state that ‘no 
one wants to’ have chemotherapy, and that there 
is ‘absolutely no point’ in having this treatment 
option. This reinforces the argument of a ‘small 
benefit’ (initially presented in line 4), and, finally, 
provides the answer to the question initially 
outlined.
This extract illustrates a form of clinical reason-
ing and ‘thinking out aloud’ to present the clini-
cian’s viewpoint. Although the patient is provided 
opportunities to participate in talk, periods of long 
silence occur as the patient’s interpretation is that 
she should wait for the clinician to come up with 
the conclusion rather than joining in.
5. Discussion
The practice of SDM can be difficult in the context 
of breast cancer when there is some uncertainty 
and differing opinions about what the ‘best’ treat-
ments may be. This study begins to identify the 
interactional details between one doctor and his 
patients during adjuvant treatment consultations, 
and foregrounds those conversational strategies 
that may be successful in hindering or enhancing 
patient participation in SDM. Overall, the findings 
suggest that sharing of treatment decision making 
in this clinical context does not happen with the 
ease implied by current models of SDM, main-
taining a paternalist approach rather than one in 
which the patient is truly empowered and involved 
in partnership.
Linguistic and interactional practices revealed 
in these findings illustrate an asymmetry of power 
divisions that reinforce societal assumptions that 
‘doctors know best’ and should make medical 
decisions on behalf of patients. The clinician in 
the present study at times sequentially positioned 
himself to convey medical authority and displayed 
an epistemic stance towards a suggested treat-
ment through pronoun use, thereby generating 
territories of expertise and potentially reducing 
patient participation (Linell and Luckmann 1991; 
Skelton et al. 2002). However, the clinician also 
deferred deontic rights and responsibility to the 
patients through invitations to decide. It could 
be argued that contradicting deontic gradients 
may obscure the question of whose decision it is. 
However, the display of subordination may also 
be a way to promote one’s own action-plans while 
maintaining the ideal of SDM, which requires com-
mitment from both parties for reaching a decision 
(Stevanovic 2012).
Other distinct interactional barriers (e.g. bound-
ary markers and rhetorical questioning) exacer-
bated the power asymmetry and complicated the 
required turn-taking needed for SDM. The idea 
that interaction between doctors and patients is 
‘asymmetrical’ has been recognised by a sample 
of women with breast cancer (Mahmoodi and 
Sargeant 2017). However, whether asymmetry 
is necessarily a barrier to SDM is questionable: 
without an asymmetric interaction, two people are 
simply ‘having a chat’, which does not reflect the 
institutional roles of the doctor and the patient. 
From a constructivist perspective of what is appro-
priate communication in a medical consultation, a 
power imbalance may conceivably be encouraging. 
The patient brings the problem, the doctor brings 
rational expertise to help solve it and offers part-
nership in action. Asymmetry can be oppressive, 
but it can equally be enabling if the clinician is 
aware of this asymmetry and is using it for shared 
good to encourage SDM. More research is needed 
to interrogate what is thus far suggested here in 
broad terms.
Equally, it is important not to obscure our 
understanding of the positive interactional work 
that surfaced during these consultations to help 
promote SDM. Although some of the conversa-
tional features displayed in this study make it hard 
not to view the clinician’s contributions as medical 
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paternalism, the deployment of other interactional 
strategies suggests a process of promoting the 
ideals of SDM and co-opting the patient to engage 
in shared responsibility of their treatment deci-
sions. For example, many techniques were utilised 
to provide patients with appropriate knowledge 
architecture and to enhance their acquisition of 
health information, which has been described 
as an essential ingredient for SDM (Moumjid 
et al. 2007): the action of rhetorical questioning 
operated as a means to elaborate and inform; the 
use of scaffolding, which incrementally builds 
to a question, aimed to enhance knowledge; and 
understanding was further facilitated through 
the use of statistics and numbers to break down 
the complexity of medical jargon and language. 
Other techniques to encourage two-way exchange 
of information included the use of adjacency 
pairs, such as the use of FPP direct questions, 
which all patients successfully recognised as 
a cue in turn taking, and therefore showed an 
‘active’, but minimalistic, participatory response 
(SPP). The subtler techniques included the use of 
preference organisation questions to help stir the 
patient towards a preferred response, and the use 
of sequential positioning of deontic stance as a 
sharing opportunity and invitation to participate 
in talk.
The overall picture, however, suggests that 
there is a misalignment between ‘best practice’ 
and pragmatism for SDM. Whilst opportunities 
for patient participation were presented in the 
conversations, the patients did not capitalise on 
these opportunities or conversational aids, which 
therefore resulted in sub-optimal two-way discus-
sions about treatment choices. When stretches of 
talk for SDM were provided, the patients resisted 
responsibility in decision making by orienting to 
a lack of own knowledge (e.g. ‘I don’t know’) and 
the contested medical knowledge (Grimen 2009). 
Unless asked a direct FPP question, they did not 
initiate conversation about treatment options at 
these points of transition. However, it should be 
acknowledged that an absence of response can 
itself be a form of participation.
In this study, the patients appeared to have 
interpreted the clinician’s turn-holding devices 
and sequential/epistemic positioning as a form of 
‘clinical reasoning’. Although they were provided 
with knowledge architecture (i.e. medical evidence) 
and were informed about the options needed to 
make appropriate trade-offs about the decision, 
they however chose not to respond and waited for 
the clinician to come up with the conclusion rather 
than themselves joining in. Therefore, it would be 
irrelevant to imply that SDM is ineffective if there 
is no two-way exchange of conversation. Rather, 
we suggest that some of the existing cues and 
conversational formats for SDM that the clinician 
displayed are not necessarily the most appropriate 
cues to initiate patient responses.
6. Conclusion
This paper highlights the utility of CA as an analyt-
ical method in revealing the kinds of interactional 
features that characterise adjuvant breast cancer 
treatment consultations, and the implications this 
might have on the materiality of SDM. Specific 
language usage can occasionally discourage patient 
participation and subsequently prevent meaningful 
SDM. However, increased awareness and training 
of both clinicians and patients on the dynamics 
of clinical conversations may increase patient 
participation. Communication skills training pro-
grammes, such as the ‘Making Good Decisions in 
Collaboration’ improvement programme (Health 
Foundation 2013), aim to support clinical teams 
to embed SDM into everyday practice by helping 
them to build coherence, improve conversational 
skills and promote positive attitudes (Elwyn et al. 
2012; Joseph-Williams et al. 2017). To improve 
SDM implementation, the use of in-consultation 
evidence-based decision-support interventions – 
such as Option Grids (Elwyn et al. 2013), patient 
decision aids (Hargreaves and Montori 2014) and 
patient activation campaigns (Shepherd et al. 2011) 
– aims to better facilitate interaction between 
patients and clinicians.
These support tools do not replace communica-
tion skills, but rather enhance information transfer, 
help patients with a prompt list of questions for 
the clinician and empower them to be involved in 
conversations about what matters to them – the 
core of SDM. For the practice of SDM to have 
meaningful impact, we recommend interventions 
and communication skills programmes to further 
aid clinicians to better understand the actual 
mechanics and cyclic patterns behind ongoing 
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interaction and when to draw upon the appro-
priate evidence-based tool to promote collabo-
ration. Rather than simply being trained in a list 
of competencies for SDM, clinicians may further 
benefit from having the skills to identify what is 
happening in conversation at a micro-analytic 
level; for example, learning to acknowledge and 
manage hesitations, silences and turn taking during 
consultations. Training programmes require some 
means of reflecting these conversational strategies 
and cues for SDM back to those involved – whether 
as part of established training procedures, or as a 
specific problem-focused approach. It may be of 
interest for future research to apply methods of CA 
to further evaluate communication skills training 
and interventions to improve communication for 
SDM.
This study is not without limitations. First, 
given the choice of a case-based study on one 
clinician, the generalisability of the findings is not 
supported, as the approach we see here may be a 
matter of this clinician’s choices and interactional 
style. The findings also cannot be generalised at 
the level of patients, as they may be also seeing 
other health professionals in the clinic too, thus 
having opportunities across these different clinical 
encounters to express participation and take part in 
SDM sequences and activities. Although the data 
generated in this study will be used to inform a 
future larger study, one way to respond to the biases 
of a case-based study is by applying a multi-case 
approach or to track a single case study over time 
(Meyer 2001).
The second limitation is that only adjuvant 
treatment consultations were examined, and 
further longitudinal studies and qualitative inter-
views are needed in order to fully understand 
how the patients adjusted to their treatment and 
the presence of SDM over time. Finally, doctor–
patient interaction was only examined among 
white, British middle-aged women patients and 
a male clinician. Doctor–patient gender and race 
concordance may influence attitudes and inter-
actions, a possibility we have not addressed in 
this study.
Despite these limitations the study provides 
valuable insight about the specific conversational 
dynamics that enhance or hinder SDM, and iden-
tifies selected communicative strategies worthy 
of further exploration. The study contributes to a 
growing body of CA research on medical decision 
making in secondary care interactions. It also 
provides theoretical contribution to the field of 
CA research, by exploring some of the complex 
asymmetries between doctors and patients in an 
institutional setting of decision making for breast 
cancer care. Further studies can examine com-
plexities and relations between these concepts 
in breast cancer care, as well as in other medical 
settings where decisions are made. Further CA 
research is recommended, with a larger sample 
of oncology clinicians with more diverse patient 
samples to explore whether our findings are 
evident beyond our case-based study observa-
tions. It is also important to understand how both 
patients and clinicians in these consultations view 
their respective contributions to the SDM process, 
and therefore subsequent semi-structured inter-
views would be a fruitful aspect of future research 
in this area.
Appendix: Transcription notation system for 
CA
Relative timing of utterances:
(0.5)  timings in whole and tenths of a second
(.)  a micro pause of less than two tenths of a 
second
=  no discernible interval between turns
[ ]  overlapping speech
Characteristics of speech delivery:
. falling intonation
here emphasis of words relative to surrounding 
talk 
↑ or ↓  speech spoken with a high or low pitch 
relative to surrounding talk
°here°  speech that is quiet or soft relative to sur-
rounding talk
>this< talk speeded up or compressed relative to 
surrounding talk
<this> talk slower or elongated relative to sur-
rounding talk
.hhh an in-breath (number of h’s indicate length)
hhh. an out-breath (number of h’s indicate 
length)
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